GW Pharmaceuticals CEO Justin Gover discusses how the company secured FDA approval for its cannabis-derived drug and what it says about the future of cannabis-derived drugs.
GW Pharma CEO on new cannabis-derived drug
Tweet on Twitter
Share on Facebook
Pinterest
